IL6 and neoplasm: Previous studies reported an increased level of IL-6 in the serum of patients with osteosarcoma77 and highlighted how IL-6, together with other cytokines (e.g. IL-878,79 and CXCL1280), promotes immunosuppressive function, increasing chemoresistance81,82 and local and systemic tumour aggressiveness83.